Related Experiment Video
Updated: Jul 6, 2025

Isolation and Enrichment of Human Adipose-derived Stromal Cells for Enhanced Osteogenesis
Published on: January 12, 2015
Adipose-derived mesenchymal stem cells (MSCs) are a superior cell source for bone tissue engineering.
Yannian Gou1,2, Yanran Huang1,3, Wenping Luo4
1Ministry of Education Key Laboratory of Diagnostic Medicine, and Department of Clinical Biochemistry, School of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China.
Adipose-derived mesenchymal stem cells (MSCs) show the greatest potential for bone tissue engineering. These cells demonstrate superior osteogenic capabilities in vitro and in vivo, making them ideal for bone regeneration applications.
Area of Science:
- Biomaterials Science
- Stem Cell Biology
- Regenerative Medicine
Background:
- Effective bone regeneration relies on osteogenic progenitors, biofactors, and scaffolds.
- Mesenchymal stem cells (MSCs) are promising seed cells for bone tissue engineering due to their multipotency.
- Various MSC sources exist, each with differing proliferative and differentiation potentials.
Purpose of the Study:
- To evaluate and compare the osteogenic potential of four distinct mouse mesenchymal stem cell (MSC) sources for bone tissue engineering.
- To identify the optimal progenitor cell source for enhanced bone regeneration applications.
Main Methods:
- Comparative analysis of proliferative activity and osteogenic potential of immortalized mouse embryonic fibroblasts (iMEF), bone marrow stromal stem cells (imBMSC), calvarial mesenchymal progenitors (iCAL), and adipose-derived mesenchymal stem cells (iMAD).
- In vitro assessment of osteogenic and adipogenic capabilities following BMP9 stimulation.
- In vivo evaluation in BMP9-induced ectopic osteogenesis and critical-sized calvarial defect repair models.
- Transcriptomic analysis to elucidate underlying molecular pathways involved in osteogenic differentiation.
Main Results:
- Adipose-derived MSCs (iMAD) exhibited the highest osteogenic and adipogenic potential in vitro upon BMP9 stimulation.
- iMAD and iCAL demonstrated superior osteogenic capability in vivo for ectopic bone formation and calvarial defect repair.
- Transcriptomic analysis revealed conserved osteogenic signaling pathway regulation (Wnt, TGF-β, PI3K/AKT, MAPK, Hippo, JAK-STAT) across all MSC lines during BMP9-induced differentiation.
Conclusions:
- Adipose-derived mesenchymal stem cells (MSCs) are the optimal progenitor source for cell-based bone tissue engineering applications.
- The findings provide crucial insights into selecting appropriate stem cell populations for regenerative medicine strategies aimed at bone repair.
More Related Videos
05:57Technique for Obtaining Mesenchymal Stem Cell from Adipose Tissue and Stromal Vascular Fraction Characterization in Long-Term Cryopreservation
Published on: December 30, 2021
10:50Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
Published on: April 7, 2023